Fair Brett 4
4 · Aclaris Therapeutics, Inc. · Filed Dec 21, 2018
Insider Transaction Report
Form 4
Fair Brett
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-12-18+1,750→ 8,513 total - Exercise/Conversion
Restricted Stock Units
2018-12-18−1,750→ 1,750 total→ Common Stock (1,750 underlying) - Tax Payment
Common Stock
2018-12-18$6.30/sh−498$3,137→ 8,015 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
- [F3]The shares underlying these restricted stock units vest in two equal annual installments on December 18, 2018 and December 18, 2019, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.